Recent 1/3 Financial Audits have focused on the accuracy of billing of medications while a member is in a skilled nursing facility (SNF). Most drugs administered during an acute stay in a SNF are covered under the global pricer for acute SNF stays. Certain high intensity chemotherapy drugs which are billed separately under Part B outside of the facility’s bundled Part A payment are an exception to the global pricer rule. However, drugs administered to Medicare beneficiaries that are in a SNF as a Long-Term Care patient or as a Nursing Home patient are covered under Part D. The 1/3 Financial Audits are reviewing medications paid under Part D to confirm the accuracy of the billing when there are medical claims denoting the member was in a SNF under an acute stay. Plans should identify members with stays in a SNF to determine if their stays were acute and should have been billed under Part A. Medical claims, TRR values, the LTI report and/or prescription drug claims should be used to identify claims inappropriately billed under Part D. Prescription drug event (PDE) data for claims identified as billed under Part D for acute stays should be reversed. Additionally, plan sponsors should outreach to the SNF facility to adjust the billing accordingly.
Reconciling Skilled Nursing Facility Drugs Payment
No Comments
Recent News
- OIG finds MAOs Inappropriately Denying Requests for PA and Payment, CMS agrees to Issue Stricter Guidance and update Audit Protocols and Auditor Training May 9, 2022
- Will Your Grievance Resolution Letters Stand Up in an Audit? February 18, 2022
- Service Spotlight: Comprehensive Support from Bid to AEP and Beyond… February 12, 2022
- The PDE Submission Deadline is Rapidly Approaching-Don’t Assume a High Acceptance Rate Translates to PDE Accuracy February 12, 2022
- Two Rules With Potential Part D Rebate Access Impact February 9, 2022
- Program Audit Consistency Teams (PACTs) February 9, 2022
- Annual Transition Policy and Attestation Submission to CMS February 9, 2022
- Why Medical Claims Audits? February 9, 2022
- Top 5 Tips to Prevent a Part D Transition Finding December 17, 2021
- Big Changes Ahead for Group Health Plans and Individual Health Plans July 29, 2021
Contact Us
BluePeak Advisors
2652 FM 407, Suite 215
Bartonville, Texas 76226
Phone: 469.319.1228
Email: info@bluepeak.com
Follow us on LinkedIn
Subscribe to Our FREE Newsletter
Related Posts
Audits
CMS One-Third Financial Audits – More Detailed Than Plans Expect

BluePeak AdvisorsMay 25, 2022
AuditsCMSMedicarePart D
Will Your Grievance Resolution Letters Stand Up in an Audit?

BluePeak AdvisorsFebruary 18, 2022
AEPMCMGMember MaterialsPart D
Service Spotlight: Comprehensive Support from Bid to AEP and Beyond…

BluePeak AdvisorsFebruary 12, 2022